Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2017/08/25 21:19:31」(JST)
[Wiki en表示]
Mycobacterium malmoense |
Scientific classification |
Kingdom: |
Bacteria |
Phylum: |
Actinobacteria |
Order: |
Actinomycetales |
Suborder: |
Corynebacterineae |
Family: |
Mycobacteriaceae |
Genus: |
Mycobacterium |
Species: |
M. malmoense |
Binomial name |
Mycobacterium malmoense
Schroder and Juhlin 1977, ATCC 29571 |
Mycobacterium malmoense is a Gram-positive bacterium from the genus Mycobacterium.
Contents
- 1 Etymology
- 2 Description
- 3 Pathogenesis
- 4 Type strain
- 5 References
- 6 External links
Etymology
From the city of Malmö, Sweden where the strain used for the description was isolated from patients.
Description
Gram-positive, nonmotile, acid-fast and coccoid to short rods.
- Environmental reservoir: soil and water.
Colony characteristics
- Smooth and nonpigmented colonies, growth below the surface of semisolid agar medium after deep inoculation (as seen with M. bovis), 0.9 - 1.7mm in diameter.
Physiology
- Growth on inspissated egg medium and oleic acid-albumin agar at a temperature range of 22°C-37°C requires over 1 week.
- Susceptible to ethambutol, ethionamide, kanamycin and cycloserine.
Differential characteristics
- Antigenic structure: seroagglutination demonstrates a single serovar distinct from that of other species.
Pathogenesis
- Usually infects young children with cervical lymphadenitis or adults with chronic pulmonary disease, (mostly with previously documented pneumoconiosis).
- Rarely causes extrapulmonary diseases and disseminated infections
- Biosafety level 2
Type strain
- First isolated from sputum and biopsy specimens with pulmonary disease in Malmö, Sweden.
Strain ATCC 29571 = CCUG 37761 = CIP 105775 = DSM 44163 = JCM 13391 = NCTC 11298.
References
- Schroder,K., I. Juhlin 1977. Mycobacterium malmoense sp. nov. International Journal of Systematic Bacteriology, 1977, 27, 241-246.]
External links
- Type strain of Mycobacterium malmoense at BacDive - the Bacterial Diversity Metadatabase
Mycobacteria (including Nontuberculous)
|
Slowly growing
(R1P=photochromogenic;
R2S=scotochromogenic;
R3N=nonchromogenic) |
Long helix 18
(TKHGC)
|
M. tuberculosis group
|
- MTC
- M. tuberculosis
- M. bovis
- M. africanum
- M. microti
- M. canetti
- M. caprae
- M. pinnipedii
- MPM
- R1P
- M. marinum
- R2S
- M. pseudoshottsii
- R3N
- M. ulcerans
- M. shottsii
- M. ulcerans liflandii
- Leprosy
- M. leprae
- M. lepraemurium
- M. lepromatosis
- R3N
- other
- M. lacus
- M. kumamotonense
|
K/H groups
|
M. kansasii group
|
- MAC
- R3N
- M. intracellulare/M. avium
- M. avium subspecies paratuberculosis
- M. chimaera
- R2S
- M. bohemicum
- GK
- R1P
- M. kansasii
- R3N
- M. gastri
- R2S
- M. nebraskense
- M. seoulense
- R3N
- M. scrofulaceum
|
M. haemophilum group
|
|
|
M. gordonae group
|
|
M. conspicuum group
|
|
|
Long helix 18
(other)
|
M. xenopi group
|
- M. botniense
- M. shimoidei/M. xenopi
- M. heckeshornense
- M. hassiacum
|
M. celatum group
|
|
M. hiberniae group
|
- M. terrae
- M. hiberniae
- M. nonchromogenicum/M. arupense
|
|
Short helix 18
|
M. simiae clade
|
- M. simiae group
- R3N
- M. genavense/M. triplex
- M. florentinum/M. montefiorense
- M. heidelbergense/M. parmense
- M. simiae
- R2S
- M. lentiflavum
- M. kubicae group
- R3N
- M. parascrofulaceum
- R2S
- M. palustre/M. kubicae
- M. interjectum group
- M. interjectum
- M. saskatchewanense
|
M. intermedium group
|
|
|
Ungrouped
|
- M. triviale
- M. doricum
- M. tusciae
- M. arosiense
|
|
Rapidly growing/
Runyon IV |
M. neoaurum group
|
- M. mageritense
- M. wolinskyi
- M. canariasense
- M. cosmeticum
- M. diernhoferi
- M. hodleri
- M. frederiksbergense
- M. neoaurum
|
F/T groups
|
M. fortuitum group
|
- M. chitae/M. fallax/M. gadium
- M. rhodesiae
- M. houstonense
- M. neworleansense/M. boenickei/M. fortuitum/M. porcinum/M. senegalense
- M. septicum/M. peregrinum/M. alvei
|
M. vaccae group
|
- M. obuense/M. gilvum/M. parafortuitum
- M. chlorophenolicum/M. chubuense
- M. psychrotolerans/M. sphagni
- M. aubagnense/M. mucogenicum/M. phocaicum
- AV
- M. aurum
- M. vanbaalenii
- M. vaccae
- M. austroafricanum
- M. pyrenivorans
|
|
M. smegmatis group
|
- M. agri/M. thermoresistibile
- M. duvalii/M. flavescens
- M. monacense
- M. pulveris/M. conceptionense/M. moriokaense
- M. novocastrense/M. brumae/M. phlei
- M. confluentis/M. madagascariense
|
M. chelonae group
|
- M. komossense
- M. murale/M. tokaiense
- M. aichiense
- M. chelonae
- M. abscessus
- M. immunogenum
- M. massiliense
- M. bolletii
|
M. elephantis group
|
- M. elephantis
- M. holsaticum
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence.
- van Ingen J, Ferro BE, Hoefsloot W, Boeree MJ, van Soolingen D.Author information Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.AbstractPulmonary disease (PD) caused by nontuberculous mycobacteria is an emerging infection mainly in countries where the incidence of tuberculosis is in decline. It affects an elderly population, often with underlying chronic lung diseases, but its epidemiology shows significant regional variation. Guidelines and recommendations for treatment of these infections exist, but build strongly on expert opinion, as very few good quality clinical trials have been performed in this field. Only for the most frequent causative agents, the Mycobacterium avium complex, Mycobacterium kansasii and Mycobacterium abscessus, a reasonable number of trials and case series is now available. For the less frequent causative agents of pulmonary nontuberculous mycobacterial (NTM) disease (Mycobacterium xenopi, Mycobacterium malmoense, Mycobacterium fortuitum, Mycobacterium chelonae) data is mostly limited to a few very small case series. Within this review, we have collected and combined evidence from all available trials and case series. From the data of these trials and case series, we reconstruct a more evidence-based overview of possible drug treatment regimens and their outcomes.
- Expert review of anti-infective therapy.Expert Rev Anti Infect Ther.2013 Oct;11(10):1065-77. doi: 10.1586/14787210.2013.830413.
- Pulmonary disease (PD) caused by nontuberculous mycobacteria is an emerging infection mainly in countries where the incidence of tuberculosis is in decline. It affects an elderly population, often with underlying chronic lung diseases, but its epidemiology shows significant regional variation. Guide
- PMID 24124798
- Disseminated infection with cutaneous involvement caused by Mycobacterium malmoense in an immunocompromised patient.
- Pigem R, Cairó M, Martínez-Lacasa X, Irigoyen D, Miró JM, Acevedo J, Fernández J, Alsina-Gibert M.
- Journal of the American Academy of Dermatology.J Am Acad Dermatol.2013 Oct;69(4):e192-3. doi: 10.1016/j.jaad.2013.04.048.
- PMID 24034397
Related Links
- Diseases Genetic and Rare Diseases Information Center (GARD) About GARD Tips for the Undiagnosed Contact GARD Feedback for GARD More Search for Genetic & Rare Diseases Search Go Browse Diseases A B C D E F G H I J
- Diseases Genetic and Rare Diseases Information Center (GARD) About GARD Tips for the Undiagnosed Contact GARD Feedback for GARD More Search for Genetic & Rare Diseases Search Go Browse Diseases A B C D E F G H I J
Related Pictures
★リンクテーブル★
[★]
- 英
- Runyon classification
- 同
- Runyon分類
- 関
- 抗酸菌
[show details]
参考
- http://www.jata.or.jp/rit/rj/319kataki10.pdf#search='%E8%BF%85%E9%80%9F%E7%99%BA%E8%82%B2%E7%BE%A4+rapid+group'
[★]
マイコバクテリウム属